Aggressive new treatment attempts to control recurrent brain tumors in young patients
NCT ID NCT01270724
Summary
This study tested an intensive two-step chemotherapy approach for children and young adults with recurrent brain germ cell tumors. First, patients received several rounds of three chemotherapy drugs, then they received very high-dose chemotherapy supported by their own previously collected stem cells. The goal was to see if this aggressive approach could control these difficult-to-treat recurrent brain tumors and extend survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CNS GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
New York University Langone Medical Center
New York, New York, 10016, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
The Ohio State University Wexner Medical Center_The James Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.